MedPath

Baclofen

These highlights do not include all the information needed to use baclofen oral solution safely and effectively. See full prescribing information for baclofen oral solution. BACLOFEN oral solution Initial U.S. Approval: 1977

Approved
Approval ID

f8ec79c6-da65-4fb6-b6bd-45df0d2a52c7

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 18, 2023

Manufacturers
FDA

TRUPHARMA, LLC

DUNS: 078533947

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Baclofen

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code52817-620
Application NumberNDA208193
Product Classification
M
Marketing Category
C73605
G
Generic Name
Baclofen
Product Specifications
Route of AdministrationORAL
Effective DateOctober 18, 2023
FDA Product Classification

INGREDIENTS (6)

PROPYLPARABENInactive
Code: Z8IX2SC1OH
Classification: IACT
GLYCERINInactive
Code: PDC6A3C0OX
Classification: IACT
METHYLPARABENInactive
Code: A2I8C7HI9T
Classification: IACT
SUCRALOSEInactive
Code: 96K6UQ3ZD4
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
BACLOFENActive
Quantity: 10 mg in 5 mL
Code: H789N3FKE8
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Baclofen - FDA Drug Approval Details